<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Data-Review" Owner="NLM">        <PMID Version="1">30158526</PMID>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>02</Day>        </DateRevised>        <Article PubModel="Electronic">            <Journal>                <ISSN IssnType="Electronic">2041-1723</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>9</Volume>                    <Issue>1</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Aug</Month>                        <Day>29</Day>                    </PubDate>                </JournalIssue>                <Title>Nature communications</Title>                <ISOAbbreviation>Nat Commun</ISOAbbreviation>            </Journal>            <ArticleTitle>In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer.</ArticleTitle>            <Pagination>                <MedlinePgn>3501</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-018-05742-z</ELocationID>            <Abstract>                <AbstractText>Triple-negative breast cancer (TNBC) lacks prognostic and predictive markers. Here, we use high-throughput phosphoproteomics to build a functional TNBC taxonomy. A cluster of 159 phosphosites is upregulated in relapsed cases of a training set (n = 34 patients), with 11 hyperactive kinases accounting for this phosphoprofile. A mass-spectrometry-to-immunohistochemistry translation step, assessing 2 independent validation sets, reveals 6 kinases with preserved independent prognostic value. The kinases split the validation set into two patterns: one without hyperactive kinases being associated with a &gt;90% relapse-free rate, and the other one showing ≥1 hyperactive kinase and being associated with an up to 9.5-fold higher relapse risk. Each kinase pattern encompasses different mutational patterns, simplifying mutation-based taxonomy. Drug regimens designed based on these 6 kinases show promising antitumour activity in TNBC cell lines and patient-derived xenografts. In summary, the present study elucidates phosphosites and kinases implicated in TNBC and suggests a target-based clinical classification system for TNBC.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Zagorac</LastName>                    <ForeName>Ivana</ForeName>                    <Initials>I</Initials>                    <AffiliationInfo>                        <Affiliation>Breast Cancer Clinical Research Unit, CNIO - Spanish National Cancer Research Center, 28029, Madrid, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Fernandez-Gaitero</LastName>                    <ForeName>Sara</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Breast Cancer Clinical Research Unit, CNIO - Spanish National Cancer Research Center, 28029, Madrid, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Penning</LastName>                    <ForeName>Renske</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Padualaan 8, 3584 CH, Utrecht, The Netherlands.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Netherlands Proteomics Center, Padualaan 8, 3584 CH, Utrecht, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Post</LastName>                    <ForeName>Harm</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Padualaan 8, 3584 CH, Utrecht, The Netherlands.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Netherlands Proteomics Center, Padualaan 8, 3584 CH, Utrecht, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bueno</LastName>                    <ForeName>Maria J</ForeName>                    <Initials>MJ</Initials>                    <AffiliationInfo>                        <Affiliation>Breast Cancer Clinical Research Unit, CNIO - Spanish National Cancer Research Center, 28029, Madrid, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Mouron</LastName>                    <ForeName>Silvana</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Breast Cancer Clinical Research Unit, CNIO - Spanish National Cancer Research Center, 28029, Madrid, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Manso</LastName>                    <ForeName>Luis</ForeName>                    <Initials>L</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-1683-550X</Identifier>                    <AffiliationInfo>                        <Affiliation>Medical Oncology, Hospital 12 de Octubre, Madrid, 28029, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Morente</LastName>                    <ForeName>Manuel M</ForeName>                    <Initials>MM</Initials>                    <AffiliationInfo>                        <Affiliation>Biobank, CNIO - Spanish National Cancer Research Center, Madrid, 28029, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Alonso</LastName>                    <ForeName>Soledad</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Pathology Department, Hospital Universitario de Guadalajara, Guadalajara, 19002, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Serra</LastName>                    <ForeName>Violeta</ForeName>                    <Initials>V</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0001-6620-1065</Identifier>                    <AffiliationInfo>                        <Affiliation>Experimental Therapeutics Group, VHIO - Vall d'Hebron Institute of Oncology, Barcelona, 08035, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Muñoz</LastName>                    <ForeName>Javier</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Proteomics Unit, CNIO - Spanish National Cancer Research Center, Madrid, 28029, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Gómez-López</LastName>                    <ForeName>Gonzalo</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>Bioinformatics Unit, CNIO - Spanish National Cancer Research Center, Madrid, 28029, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lopez-Acosta</LastName>                    <ForeName>Jose Francisco</ForeName>                    <Initials>JF</Initials>                    <AffiliationInfo>                        <Affiliation>Breast Cancer Clinical Research Unit, CNIO - Spanish National Cancer Research Center, 28029, Madrid, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Jimenez-Renard</LastName>                    <ForeName>Veronica</ForeName>                    <Initials>V</Initials>                    <AffiliationInfo>                        <Affiliation>Breast Cancer Clinical Research Unit, CNIO - Spanish National Cancer Research Center, 28029, Madrid, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Gris-Oliver</LastName>                    <ForeName>Albert</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Experimental Therapeutics Group, VHIO - Vall d'Hebron Institute of Oncology, Barcelona, 08035, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Al-Shahrour</LastName>                    <ForeName>Fatima</ForeName>                    <Initials>F</Initials>                    <AffiliationInfo>                        <Affiliation>Bioinformatics Unit, CNIO - Spanish National Cancer Research Center, Madrid, 28029, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Piñeiro-Yañez</LastName>                    <ForeName>Elena</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>Bioinformatics Unit, CNIO - Spanish National Cancer Research Center, Madrid, 28029, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Montoya-Suarez</LastName>                    <ForeName>Jose Luis</ForeName>                    <Initials>JL</Initials>                    <AffiliationInfo>                        <Affiliation>Medical Oncology, Hospital Nacional Guillermo Almenara Irigoyen - ESSALUD, Lima, 15033, Peru.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Apala</LastName>                    <ForeName>Juan V</ForeName>                    <Initials>JV</Initials>                    <AffiliationInfo>                        <Affiliation>Breast Cancer Clinical Research Unit, CNIO - Spanish National Cancer Research Center, 28029, Madrid, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Moreno-Torres</LastName>                    <ForeName>Amalia</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Pathology Department, Hospital Universitario de Fuenlabrada, Fuenlabrada, 28942, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Colomer</LastName>                    <ForeName>Ramon</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Medical Oncology, Hospital La Princesa, Madrid, 28006, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Dopazo</LastName>                    <ForeName>Ana</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Genomics Unit, CNIC - Spanish National Center for Cardiovascular Research, Madrid, 28029, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Heck</LastName>                    <ForeName>Albert J R</ForeName>                    <Initials>AJR</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-2405-4404</Identifier>                    <AffiliationInfo>                        <Affiliation>Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Padualaan 8, 3584 CH, Utrecht, The Netherlands.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Netherlands Proteomics Center, Padualaan 8, 3584 CH, Utrecht, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Altelaar</LastName>                    <ForeName>Maarten</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Padualaan 8, 3584 CH, Utrecht, The Netherlands.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Netherlands Proteomics Center, Padualaan 8, 3584 CH, Utrecht, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Quintela-Fandino</LastName>                    <ForeName>Miguel</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Breast Cancer Clinical Research Unit, CNIO - Spanish National Cancer Research Center, 28029, Madrid, Spain. mquintela@cnio.es.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Medical Oncology, Hospital Universitario Fuenlabrada, Madrid, 28942, Spain. mquintela@cnio.es.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Medical Oncology, Hospital Universitario Quirón, Madrid, 28223, Spain. mquintela@cnio.es.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>CP14/00228</GrantID>                    <Agency>Ministerio de Sanidad, Servicios Sociales e Igualdad (Ministry of Health, Social Services and Equality)</Agency>                    <Country/>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>29</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>Nat Commun</MedlineTA>            <NlmUniqueID>101528555</NlmUniqueID>            <ISSNLinking>2041-1723</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Proteomics. 2009 Mar;9(6):1451-68</RefSource>                <PMID Version="1">19235172</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2014 Mar 13;33(11):1385-94</RefSource>                <PMID Version="1">23542175</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Protoc. 2013 Mar;8(3):461-80</RefSource>                <PMID Version="1">23391890</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proteomics. 2014 Mar;14(4-5):441-51</RefSource>                <PMID Version="1">24339433</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2005 Mar;90(2):157-63</RefSource>                <PMID Version="1">15803362</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50</RefSource>                <PMID Version="1">16199517</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nucleic Acids Res. 2016 Jan 4;44(D1):D447-56</RefSource>                <PMID Version="1">26527722</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Invest. 2011 Jul;121(7):2750-67</RefSource>                <PMID Version="1">21633166</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Res. 2012 Apr;22(4):620-3</RefSource>                <PMID Version="1">22310242</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2013 Oct 17;502(7471):333-339</RefSource>                <PMID Version="1">24132290</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2010 Nov 11;363(20):1938-48</RefSource>                <PMID Version="1">21067385</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Blood. 2000 Aug 1;96(3):925-32</RefSource>                <PMID Version="1">10910906</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Expert Rev Proteomics. 2011 Feb;8(1):81-94</RefSource>                <PMID Version="1">21329429</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Biotechnol. 2007 Mar;25(3):285-6</RefSource>                <PMID Version="1">17344875</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2009 Oct 15;15(20):6327-40</RefSource>                <PMID Version="1">19808870</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biometrics. 1979 Sep;35(3):623-30</RefSource>                <PMID Version="1">497345</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7</RefSource>                <PMID Version="1">27141961</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Bioinformatics. 2013 Jul 1;29(13):1687-9</RefSource>                <PMID Version="1">23630175</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Commun. 2017 Mar 28;8:14864</RefSource>                <PMID Version="1">28348404</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Proteome Res. 2011 May 6;10(5):2377-88</RefSource>                <PMID Version="1">21413819</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell Proteomics. 2014 Sep;13(9):2426-34</RefSource>                <PMID Version="1">24850871</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Discov. 2016 Jun;6(6):650-63</RefSource>                <PMID Version="1">27179036</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Genet. 2013 Jan;14(1):35-48</RefSource>                <PMID Version="1">23207911</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell. 2016 Aug 11;166(4):1041-1054</RefSource>                <PMID Version="1">27499020</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nucleic Acids Res. 2017 Jan 4;45(D1):D777-D783</RefSource>                <PMID Version="1">27899578</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2012 Jun 10;486(7403):353-60</RefSource>                <PMID Version="1">22722193</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Med. 2016 Nov;22(11):1303-1313</RefSource>                <PMID Version="1">27775704</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Transl Oncol. 2010 Mar;12(3):174-80</RefSource>                <PMID Version="1">20231122</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Bioinformatics. 2005 May 1;21(9):2067-75</RefSource>                <PMID Version="1">15657102</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell Proteomics. 2011 Oct;10(10):M110.006452</RefSource>                <PMID Version="1">21715320</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Med. 2016 Nov;22(11):1321-1329</RefSource>                <PMID Version="1">27775705</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lab Invest. 2015 May;95(5):561-71</RefSource>                <PMID Version="1">25730369</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2009;11(5):R77</RefSource>                <PMID Version="1">19874578</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2012 Apr 04;486(7403):395-9</RefSource>                <PMID Version="1">22495314</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Biotechnol. 2008 Dec;26(12):1367-72</RefSource>                <PMID Version="1">19029910</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nucleic Acids Res. 2016 Jan 4;44(D1):D862-8</RefSource>                <PMID Version="1">26582918</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2015 Apr 1;21(7):1688-98</RefSource>                <PMID Version="1">25208879</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Bioinformatics. 2013 Apr 15;14:128</RefSource>                <PMID Version="1">23586463</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2012 Apr 18;486(7403):346-52</RefSource>                <PMID Version="1">22522925</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2012 Oct 4;490(7418):61-70</RefSource>                <PMID Version="1">23000897</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Rep. 2015 Apr 28;11(4):630-44</RefSource>                <PMID Version="1">25892236</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Med Chem. 2016 Jun 23;59(12):5650-60</RefSource>                <PMID Version="1">27227380</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2012 May 16;486(7403):400-4</RefSource>                <PMID Version="1">22722201</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 1996 Jan 1;56(1):100-4</RefSource>                <PMID Version="1">8548747</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2016 May 25;534(7605):55-62</RefSource>                <PMID Version="1">27251275</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2008 Oct;19(10):1713-9</RefSource>                <PMID Version="1">18515258</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Methods. 2009 May;6(5):359-62</RefSource>                <PMID Version="1">19377485</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2012 Mar 28;483(7391):603-7</RefSource>                <PMID Version="1">22460905</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Expert Rev Proteomics. 2015 Jun;12(3):235-53</RefSource>                <PMID Version="1">25955281</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Invest. 2012 Apr;122(4):1541-52</RefSource>                <PMID Version="1">22446188</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Anal Chem. 2016 Jan 5;88(1):74-94</RefSource>                <PMID Version="1">26539879</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2009 Oct 1;69(19):7739-46</RefSource>                <PMID Version="1">19773431</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2014 Sep 1;74(17):4822-35</RefSource>                <PMID Version="1">24970481</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Med. 2015 Nov;21(11):1318-25</RefSource>                <PMID Version="1">26479923</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cancer Ther. 2004 Nov;3(11):1427-38</RefSource>                <PMID Version="1">15542782</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2012 Jun 20;486(7403):405-9</RefSource>                <PMID Version="1">22722202</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2016 May 02;534(7605):47-54</RefSource>                <PMID Version="1">27135926</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2012 May 17;31(20):2593-600</RefSource>                <PMID Version="1">21996750</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Surg. 2013 Mar;100(4):490-6</RefSource>                <PMID Version="1">23319435</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Oncol. 2014 Mar;44(3):735-44</RefSource>                <PMID Version="1">24378347</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 2012 Aug 17;287(34):29075-87</RefSource>                <PMID Version="1">22733811</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell. 2016 Jul 28;166(3):755-765</RefSource>                <PMID Version="1">27372738</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Bioinformatics. 2010 Aug 15;26(16):2069-70</RefSource>                <PMID Version="1">20562413</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Struct Mol Biol. 2010 Jun;17(6):666-72</RefSource>                <PMID Version="1">20495563</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2014 May 29;509(7502):575-81</RefSource>                <PMID Version="1">24870542</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74</RefSource>                <PMID Version="1">11553815</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell Proteomics. 2014 Jul;13(7):1690-704</RefSource>                <PMID Version="1">24719451</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell. 2014 Aug 28;158(5):1199-1209</RefSource>                <PMID Version="1">25171417</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Biotechnol. 2013 Mar;31(3):213-9</RefSource>                <PMID Version="1">23396013</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 2014 Mar;50(5):867-75</RefSource>                <PMID Version="1">24440085</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2017</Year>                <Month>09</Month>                <Day>15</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>19</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>31</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>31</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>31</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30158526</ArticleId>            <ArticleId IdType="doi">10.1038/s41467-018-05742-z</ArticleId>            <ArticleId IdType="pii">10.1038/s41467-018-05742-z</ArticleId>            <ArticleId IdType="pmc">PMC6115463</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>